CLONIDINE TREATMENT FOR PTSD IN CHILDREN

可乐定治疗儿童创伤后应激障碍

• 批准号: 6122609
• 负责人: STEVEN M M SOUTHWICK
• 金额: $ 2.58万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6122609
• 关键词: catecholamines; child (0-11); clinical research; clonidine; human subject; human therapy evaluation; mental disorder chemotherapy; pediatric pharmacology; placebos; posttraumatic stress disorder; sign /symptom

Treatment of Post Traumatic Stress Syndrome (PTSD) symptoms with either clonidine or placebo will be compared in traumatized children. The relationship between PTSD symptomatology, catecholamines, and response to clonidine will also be compared.

将在创伤儿童中比较可乐定或安慰剂对创伤后应激综合征（PTSD）症状的治疗。 还将比较PTSD病理学、儿茶酚胺和可乐定反应之间的关系。